MENU
+Compare
AKAN
Stock ticker: NASDAQ
AS OF
Nov 13, 04:59 PM (EDT)
Price
$1.29
Change
-$0.04 (-3.01%)
Capitalization
997.76K

AKAN Akanda Corp Forecast, Technical & Fundamental Analysis

Akanda Corp is a cannabis cultivation, manufacturing, and distribution company... Show more

AKAN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for AKAN with price predictions
Nov 12, 2025

Momentum Indicator for AKAN turns negative, indicating new downward trend

AKAN saw its Momentum Indicator move below the 0 level on October 27, 2025. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 68 similar instances where the indicator turned negative. In of the 68 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AKAN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for AKAN entered a downward trend on November 10, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 11 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Moving Average Convergence Divergence (MACD) for AKAN just turned positive on November 12, 2025. Looking at past instances where AKAN's MACD turned positive, the stock continued to rise in of 34 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AKAN advanced for three days, in of 142 cases, the price rose further within the following month. The odds of a continued upward trend are .

AKAN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.302) is normal, around the industry mean (18.827). P/E Ratio (0.044) is within average values for comparable stocks, (71.764). AKAN's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.856). AKAN has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.031). P/S Ratio (0.688) is also within normal values, averaging (39.291).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. AKAN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AKAN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
AKAN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
N/A
Address
1A, 1B Learoyd Road
Phone
+44 2034889514
Employees
46
Web
https://www.akandacorp.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ACRV2.280.21
+10.14%
Acrivon Therapeutics
EYE24.740.61
+2.53%
National Vision Holdings
CR190.982.80
+1.49%
Crane Company
FFWM5.08-0.04
-0.78%
First Foundation
BHFAM11.80-0.16
-1.34%
Brighthouse Financial

AKAN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, AKAN has been loosely correlated with CRON. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if AKAN jumps, then CRON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AKAN
1D Price
Change %
AKAN100%
-0.75%
CRON - AKAN
36%
Loosely correlated
+0.79%
TLRY - AKAN
35%
Loosely correlated
-4.65%
ACB - AKAN
31%
Poorly correlated
-0.44%
OGI - AKAN
29%
Poorly correlated
-1.83%
CGC - AKAN
27%
Poorly correlated
-0.83%
More

Groups containing AKAN

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AKAN
1D Price
Change %
AKAN100%
-0.75%
Pharmaceuticals: Generic
industry (214 stocks)
22%
Poorly correlated
-1.00%